Autism Spectrum Disorder and Complementary-Integrative Medicine.

Author: ArnoldL Eugene, HendrenRobert L, SimkinDeborah R, VandanaPankhuree

Paper Details 
Original Abstract of the Article :
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 0.6%-1.7% of children. The etiology of autism is hypothesized to include both biological and environmental factors (Watts, 2008). In addition to the core symptoms of social-communication delay and restricted, repetitive int...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.chc.2022.08.004

データ提供:米国国立医学図書館(NLM)

Autism Spectrum Disorder and Complementary-Integrative Medicine: A Growing Trend

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects millions of individuals worldwide. While research continues to advance our understanding of ASD, there is still no cure or FDA-approved medication that specifically targets the core symptoms of the disorder. This research delves into the growing trend of families seeking complementary-integrative medicine (CIM) treatments for their children with ASD, exploring the motivations behind this approach and examining the evidence for the efficacy and safety of these treatments.

The study highlights the challenges of treating ASD and the unmet needs of families seeking alternative therapies. The study found that a significant proportion of families with children with ASD utilize CIM treatments, often driven by concerns about potential side effects of conventional medications and a desire for more natural approaches. The study explores the most commonly used CIM treatments, including multivitamins, elimination diets, and methyl B12 injections, and examines the evidence for their effectiveness. It also discusses the importance of open communication between healthcare providers and families regarding CIM usage, emphasizing the need for evidence-based decision-making and informed consent. It's like a camel caravan, seeking a variety of resources to meet the unique needs of its members, navigating the challenging landscape of ASD treatment.

Complementary-Integrative Medicine: A Bridge Between Conventional and Alternative Therapies

The study underscores the importance of incorporating a holistic perspective when considering treatments for ASD, acknowledging the value of both conventional and complementary approaches. It encourages open communication and collaborative decision-making between healthcare providers and families, recognizing that the best treatment plan is often a combination of evidence-based medicine and personalized choices. It's like a camel caravan, strategically combining its strengths and resources to overcome obstacles and reach its final destination.

Navigating the Path to Better ASD Treatment

This research highlights the ongoing search for effective and safe treatments for ASD. It emphasizes the importance of research, open communication, and collaboration between healthcare professionals and families to develop a more comprehensive understanding of the potential benefits and risks of both conventional and complementary therapies. It's like a camel caravan, guided by a map of knowledge and a compass of empathy, navigating the ever-changing landscape of ASD research and treatment.

Dr.Camel's Conclusion

This research reminds us that the desert of ASD treatment is vast and complex, with no single solution that fits all. By embracing a multi-faceted approach that incorporates both conventional and complementary therapies, we can empower families to make informed choices that best meet their unique needs. It's like a camel caravan, utilizing its collective wisdom and resilience to navigate the challenging terrain of ASD, seeking to provide comfort, support, and hope for all those affected by this complex disorder.

Date :
  1. Date Completed 2023-05-08
  2. Date Revised 2023-05-10
Further Info :

Pubmed ID

37147047

DOI: Digital Object Identifier

10.1016/j.chc.2022.08.004

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.